[1] |
Tang W, Makuuchi M. Intractable and rare diseases research[J]. Intractable Rare Dis Res, 2012, 1(1):1-2. doi: 10.5582/irdr.2012.v1.1.1.
doi: 10.5582/irdr.2012.v1.1.1
|
[2] |
Montserrat Moliner A, Waligóra J. The European union policy in the field of rare diseases[J]. Public Health Genomics, 2013, 16(6):268-277. doi: 10.1159/000355930.
doi: 10.1159/000355930
pmid: 24503587
|
[3] |
Lim SS, Lee W, Kim YK, et al. The cumulative incidence and trends of rare diseases in South Korea: a nationwide study of the administrative data from the National Health Insurance Service database from 2011-2015[J]. Orphanet J Rare Dis, 2019, 14(1):49. doi: 10.1186/s13023-019-1032-6.
doi: 10.1186/s13023-019-1032-6
URL
|
[4] |
Rath A, Olry A, Dhombres F, et al. Representation of rare diseases in health information systems: the Orphanet approach to serve a wide range of end users[J]. Hum Mutat, 2012, 33(5):803-808. doi: 10.1002/humu.22078.
doi: 10.1002/humu.22078
pmid: 22422702
|
[5] |
Whicher D, Philbin S, Aronson N. An overview of the impact of rare disease characteristics on research methodology[J]. Orphanet J Rare Dis, 2018, 13(1):14. doi: 10.1186/s13023-017-0755-5.
doi: 10.1186/s13023-017-0755-5
URL
|
[6] |
马端, 李定国, 张学, 等. 中国罕见病防治的机遇与挑战[J]. 中国循证儿科杂志, 2011, 6(2):81-82. doi: 10.3969/j.issn.1673-5501.2011.02.001.
doi: 10.3969/j.issn.1673-5501.2011.02.001
|
[7] |
Zurynski Y, Deverell M, Dalkeith T, et al. Australian children living with rare diseases: experiences of diagnosis and perceived consequences of diagnostic delays[J]. Orphanet J Rare Dis, 2017, 12(1):68. doi: 10.1186/s13023-017-0622-4.
doi: 10.1186/s13023-017-0622-4
pmid: 28399928
|
[8] |
Al-Qusairi L, Prokic I, Amoasii L, et al. Lack of myotubularin (MTM1) leads to muscle hypotrophy through unbalanced regulation of the autophagy and ubiquitin-proteasome pathways[J]. FASEB J, 2013, 27(8):3384-3394. doi: 10.1096/fj.12-220947.
doi: 10.1096/fj.12-220947
pmid: 23695157
|
[9] |
Haendel M, Vasilevsky N, Unni D, et al. How many rare diseases are there?[J]. Nat Rev Drug Discov, 2020, 19(2):77-78. doi: 10.1038/d41573-019-00180-y.
doi: 10.1038/d41573-019-00180-y
URL
|
[10] |
Derayeh S, Kazemi A, Rabiei R, et al. National information system for rare diseases with an approach to data architecture: A systematic review[J]. Intractable Rare Dis Res, 2018, 7(3):156-163. doi: 10.5582/irdr.2018.01065.
doi: 10.5582/irdr.2018.01065
URL
|
[11] |
温馨, 王杉杉, 蔡剑, 等. 浙江省2007—2017年罕见病住院病例特征分析[J]. 中华流行病学杂志, 2020, 41(3):400-405. doi: 10.3760/cma.j.issn.0254-6450.2020.03.027.
doi: 10.3760/cma.j.issn.0254-6450.2020.03.027
|
[12] |
Pai M, Yeung C, Akl EA, et al. Strategies for eliciting and synthesizing evidence for guidelines in rare diseases[J]. BMC Med Res Methodol, 2019, 19(1):67. doi: 10.1186/s12874-019-0713-0.
doi: 10.1186/s12874-019-0713-0
URL
|
[13] |
Comprehensive gene panels provide advantages over clinical exome sequencing for Mendelian diseases[J]. Genome Biol, 2015, 16(1):134. doi: 10.1186/s13059-015-0693-2.
doi: 10.1186/s13059-015-0693-2
URL
|
[14] |
陈玉林, 余章斌, 韩树萍, 等. 新生儿瓜氨酸血症1例报道并文献复习[J]. 中国循证儿科杂志, 2010, 5(6):452-457. doi: 10.3969/j.issn.1673-5501.2010.06.010.
doi: 10.3969/j.issn.1673-5501.2010.06.010
|
[15] |
Nimkarn S, New MI. Prenatal diagnosis and treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency[J]. Mol Cell Endocrinol, 2009, 300(1/2):192-196. doi: 10.1016/j.mce.2008.11.027.
doi: 10.1016/j.mce.2008.11.027
URL
|
[16] |
Tasfaout H, Cowling BS, Laporte J. Centronuclear myopathies under attack: A plethora of therapeutic targets[J]. J Neuromuscul Dis, 2018, 5(4):387-406. doi: 10.3233/JND-180309.
doi: 10.3233/JND-180309
pmid: 30103348
|
[17] |
刘梦娴, 李思涛, 梁宇珊, 等. 新生儿猝死型肉碱-酰基肉碱移位酶缺乏症患儿的临床特征及基因变异分析[J]. 中华实用儿科临床杂志, 2019, 34(19):1496-1499. doi: 10.3760/cma.j.issn.2095-428X.2019.19.014.
doi: 10.3760/cma.j.issn.2095-428X.2019.19.014
|
[18] |
陆炜, 罗飞宏, 吴梦圆, 等. 新生儿肉碱-酰基肉碱移位酶缺乏症的临床特征及基因诊断[J]. 发育医学电子杂志, 2019, 7(4):269-273. doi: 10.3969/j.issn.2095-5340.2019.04.007.
doi: 10.3969/j.issn.2095-5340.2019.04.007
|
[19] |
王晓, 王迪, 滕宏琴. 内蒙古地区首例猫叫综合征患儿病例报告[J]. 中国优生与遗传杂志, 2013, 21(3):49-50. doi: 10.13404/j.cnki.cjbhh.2013.03.053.
doi: 10.13404/j.cnki.cjbhh.2013.03.053
|
[20] |
Zhang A, Zheng C, Hou M, et al. Deletion of the telomerase reverse transcriptase gene and haploinsufficiency of telomere maintenance in Cri du chat syndrome[J]. Am J Hum Genet, 2003, 72(4):940-948. doi: 10.1086/374565.
doi: 10.1086/374565
pmid: 12629597
|
[21] |
中华医学会儿科学分会内分泌遗传代谢学组, 中华预防医学会中华预防医学会出生缺陷预防与控制专业. 高苯丙氨酸血症的诊治共识[J]. 中华儿科杂志, 2014, 52(6):420-425. doi: 10.3760/cma.j.issn.0578-1310.2014.06.005.
doi: 10.3760/cma.j.issn.0578-1310.2014.06.005
|
[22] |
罗飞宏. 先天性肾上腺皮质增生症诊断治疗进展[J]. 中华实用儿科临床杂志, 2015, 30(8):564-569. doi: 10.3760/cma.j.issn.2095-428X.2015.08.002.
doi: 10.3760/cma.j.issn.2095-428X.2015.08.002
|
[23] |
Schimmer J, Breazzano S. Investor Outlook: Rising from the Ashes; GSK′s European Approval of Strimvelis for ADA-SCID[J]. Hum Gene Ther Clin Dev, 2016, 27(2):57-61. doi: 10.1089/humc.2016.29010.ind.
doi: 10.1089/humc.2016.29010.ind
pmid: 27267267
|
[24] |
郭健, 吕浩涵, 李杰, 等. 中国国家罕见病注册系统架构和数据质量控制及管理流程[J]. 中国数字医学, 2021, 16(1):17-22. doi: 10.3969/j.issn.1673-7571.2021.01.004.
doi: 10.3969/j.issn.1673-7571.2021.01.004
|
[25] |
刘卫卫, 孙莹璞. 代谢组学及其在辅助生殖技术中的应用前景[J]. 国际生殖健康/计划生育杂志, 2010, 29(4):271-273,308. doi: 10.3969/j.issn.1674-1889.2010.04.009.
doi: 10.3969/j.issn.1674-1889.2010.04.009
|